st CY14 est's to $180B/=$43.90 (vs. prior to $184B/ $46.00) and introduce CY15 of $188B/ $48.35. Our $575 PT is unchanged and is based on —9x CY14E EV/FCF; the lower end of its historical 7-29x range. We view the multiple as appropriate given AAPC=;s growth/profit profile. Risks include product executi